Abstract:Objective To investigate whether propofol alleviates cerebral ischemia/reperfusion (I/R) injury by modulating the BPI fold-containing family B member 1 (BPIFB1)/Toll-like receptor 4 (TLR4) pathway to influence microglial polarization. Methods A middle cerebral artery occlusion (MCAO) model was established in mice and divided into sham operation group, MCAO model group, and MCAO + propofol group. TTC staining, neurological function scoring, immunofluorescence, qPCR, and Western blot were used to assess cerebral injury, microglial polarization, and BPIFB1/TLR4 expression. An oxygen-glucose deprivation (OGD) model was constructed in BV2 microglial cells and divided into control group, OGD model group, and OGD + propofol group. Immunofluorescence, qPCR, and Western blot were employed to examine the polarization status and BPIFB1/TLR4 expression. Additionally, molecular docking and siRNA knockdown techniques were applied to analyze the interaction between propofol and BPIFB1 as well as the function of BPIFB1. Results In vivo, propofol significantly improved neurological function, reduced cerebral infarct volume and edema, inhibited M1 polarization while promoting M2 polarization of microglia, and upregulated BPIFB1 while downregulating TLR4 expression (P < 0.05). In vitro, propofol pretreatment inhibited OGD-induced M1 polarization, promoted M2 polarization, and correspondingly altered BPIFB1 and TLR4 protein levels (P < 0.05). Molecular docking suggested a potential binding affinity between propofol and BPIFB1. Knockdown of BPIFB1 reversed propofol's effects on promoting M2 polarization, inhibiting TLR4, and its cytoprotective action (P < 0.05). Conclusion Propofol protects against cerebral I/R injury by modulating the BPIFB1/TLR4 pathway to shift microglial polarization to the protective M2 phenotype.